Zev Wajsman

3.3k citations
83 papers · 2.5k indexed · h-index 25
Topics
Bladder and Urothelial Cancer Treatments (34 papers)Prostate Cancer Diagnosis and Treatment (21 papers)Urinary and Genital Oncology Studies (21 papers)

In The Last Decade

Zev Wajsman

79 papers receiving 2.4k citations

Peers

Zev Wajsman
Comparison fields: 5 of 102
  • Pulmonary and Respiratory Medicine 1.3k
  • Surgery 1.2k
  • Urology 460
  • Rheumatology 400
  • Oncology 324
Replace Hwang Gyun Jeon with:
Hwang Gyun Jeon South Korea
Costantino Leonardo Italy
Joseph W. Basler United States
Libni Eapen Canada
J.M. Wolff Germany
Stephan Roth Germany
Tracy M. Downs United States
Stephen B. Strum United States
Rabi Tiguert United States
Giuseppe Carrieri Italy
Zev Wajsman relative to Hwang Gyun Jeon South Korea Hwang Gyun Jeon's profile →
Citations per field
00.5×1.5×
Hwang Gyun Jeon · 1×
Citations per year

Countries citing papers authored by Zev Wajsman

Since Specialization
Citations

This map shows the geographic impact of Zev Wajsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zev Wajsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zev Wajsman more than expected).

Fields of papers citing papers by Zev Wajsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zev Wajsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zev Wajsman. The network helps show where Zev Wajsman may publish in the future.

Co-authorship network of co-authors of Zev Wajsman

This figure shows the co-authorship network connecting the top 25 collaborators of Zev Wajsman. A scholar is included among the top collaborators of Zev Wajsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zev Wajsman. Zev Wajsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 48
3 152
4 1
5 4
6 29
7 23
8 26
9 1
10 17
11 4
12 52
13 3
14 19
15 46
16 37
17 24
18 3
19 5
20 2

About Zev Wajsman

Zev Wajsman is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine, having authored 83 papers that have together received 2.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (34 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Urinary and Genital Oncology Studies (21 papers). The work is most often cited by research in Urology (460 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Surgery (1.2k citations). Zev Wajsman has collaborated with scholars based in United States, Israel and France. Frequent co-authors include Mark S. Soloway, David P. Wood, Antonio Puras-Báez, David G. McLeod, J. Edson Pontes, Robert P. Huben, Ira Klimberg, Roohollah Sharifi, Mark Garzotto and Robert Bahnson. Their work appears in journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026